A note from our 2024 Corporate Honoree:
At Oxy, strengthening the communities where we live and work is among our highest priorities. One of our core values is to Commit to Good through community partnerships and charitable initiatives to help address social needs, create economic opportunities, and promote human development.
We focus on areas where we believe we can positively affect the most lives and make the strongest impact, including Health and Safety, Education, Social Services, Military and Veterans, Environment, and Business and Civic Goodwill.
Oxy’s partnership with the American Cancer Society (ACS) assists patients through the Road to Recovery, Reach to Recovery and Hope Lodge programs.
In 2023, ACS announced a new partnership with Oxy to help lead the fight for a world without cancer. The Healthy Community Initiative will provide an ACS Quality Improvement Coach to support large healthcare systems helping the medically underserved. The program will assess clinical policy and practices to ensure patients receive timely screening, follow-up navigation, quality cancer diagnostics and treatment when necessary. Eliminating disparities in cancer is an overarching goal of the ACS and Oxy.
Our Houston-area partnerships include the Houston Methodist Foundation, American Red Cross, Houston Astros and Astros Foundation, Houston Livestock Show & Rodeo, Houston Food Bank, Target Hunger, Houston Habitat for Humanity, Barbara Bush Houston Literacy Foundation, and more.
About our 2024 Community Honoree:
We are thrilled to recognize the Tsuru Family as our 2024 Community Honoree. The Tsurus are long-time supporters of the life-saving mission of the American Cancer Society. Frank, a cancer survivor himself, and wife Stephanie, participated in the 2018 Men Wear Pink of Houston campaign where Frank finished in the top 5 ambassadors for funds raised. Stephanie is co-founder and CEO of SheSpace, a premier woman-focused co-working, which is the presenting sponsor of our American Cancer Society Shuck Cancer Houston, a fun, foodie event in its 3rd year. Making it a family affair, Katie and Seth Tsuru served as 2023 Event Co-Chairs for Shuck Cancer Houston and have graciously returned to serve again for 2024. In addition, Katie has recently joined our Cattle Baron’s Ball committee and will be helping with the VIP Party this year.
The Tsuru Family are also supporters of several other worthy Houston philanthropic organizations including the Houston Ballet, Hermann Park Conservancy, Barbara Bush Houston Literacy Foundation, and AVDA to name a few.
Thank you to the Tsuru Family for all that you give to the American Cancer Society and the Houston community.
About our 2024 Medical Honoree:
In 2019, John Styles, Jr., and Matt Palmer co-founded Legion Healthcare Partners, a pioneering company with the singular mission of combating cancer through the advancement of proton therapy. Legion’s objective is to remove barriers to entry and broadening access to cutting-edge treatments. The foundation of Legion was preceded by Styles and Palmer’s successful 18 year public private partnership with The University of Texas MD Anderson Cancer Center. Their collaborative effort aimed to highlight the clinical and economic advantages of proton therapy, setting a new standard in cancer treatment. Over the course of 18 years, they have assisted in treating thousands of patients globally, showcasing the impact of their work. Currently, Legion collaborates with an impressive roster of clinical partners, including MD Anderson Cancer Center, Mass General Brigham, Duke Cancer Institute, University of California San Francisco, Froedtert and the Medical College of Wisconsin, New York Proton Therapy Center, University of Maryland Proton Therapy Center, Thomas Jefferson University/Jefferson Health, University of Colorado/Colorado Children’s Hospital, among many others. These partnerships focus on integrating the latest technology and operational efficiencies into nonprofit health systems, extending the reach of advanced cancer care. Through their efforts, Legion and its partners are at the forefront in advanced solutions in cancer treatment.